| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 25.08. | Before You Sign That AI Contract: 7 Questions Every Healthcare CFO Should Ask | ||
| 25.08. | 4 Patients Injured After Drug Mix-Up at Ascension Hospital in Nashville | ||
| 24.08. | Amazon Taps Expressable for Health Benefits Connector | ||
| 24.08. | Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle | ||
| 24.08. | A Partnership-driven Approach to Waste and Abuse Prevention | ||
| 24.08. | Why Psychiatry Can't Ignore Metabolic Health Anymore | ||
| 23.08. | Ambient Scribes Improve Clinician Retention, Cleveland Clinic Research Shows | ||
| 23.08. | Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved Drugs | ||
| 23.08. | Cityblock to Acquire Homeward Health, Secures $116M Series E | ||
| 23.08. | How to Prepare Your Hospital Before H.R. 1 Hits in 2027 | ||
| 21.08. | Ambros Therapeutics' Path for Pain Drug Goes Through Reverse Merger With Werewolf Therapeutics | ||
| 21.08. | The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room | ||
| 21.08. | Modernizing Payment Integrity in an Era of Systemic Fraud | ||
| 21.08. | SCAN, Costco Launch Medicare Partnership | ||
| 20.08. | Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease | ||
| 20.08. | The Imperative of Distinguishing Medical-Grade Devices from Wellness Tech | ||
| 20.08. | AI in Pharmacovigilance: Why Governance Will Define Success | ||
| 19.08. | Happy Health Snags $75M to Support Home-Based Care | ||
| 19.08. | Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma | ||
| 19.08. | Why Bone Health Is Preventive Healthcare's Next Big Category | ||
| 19.08. | Included Health Taps Carrum Health for Value-Based Specialty Care | ||
| 18.08. | Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition | ||
| 18.08. | Rural US Healthcare Has A Cybersecurity Problem - CMS Funding Can Help Fix the Part No One Sees | ||
| 18.08. | KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 | ||
| 17.08. | Slate Medicines' Merger and $245M Private Placement Fuel Mission in Migraine |